Asian Spectator

Men's Weekly

.

Orpha Labs AG Announces the Initiation of a Phase III Trial Ev...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
BAAR, Switzerland, Feb 23, 2022, /PRNewswire-AsiaNet/-- Orpha Labs AG, a clinical-stage biopharmaceutical company focused on diseases with unmet needs, today announced the initiation of the Phase III trial with ORL-101 in patients with Leukocyte Adhesion Deficiency Type II (“LAD-II”). Orpha Labs AG is ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Kenapa nilai zakat Indonesia masih rendah meski pembayaran zakat digital sudah di mana-mana?

● Potensi zakat nasional tembus ratusan triliun.● Dana sebesar itu bisa jadi dana segar pembangunan dan pengentasan kemiskinan nasional.● Pembayaran online ternyata tak mendongkrak p...

‘Lebaran blues’ dan rasa kehilangan: Bagaimana momen hari raya bisa memicu duka

Tampak belakang seorang perempuan mengenakan pakaian salat duduk di kursi roda pada perayaan Idulfitri.Creativa Images/Shutterstock● Bagi mereka yang sedang berduka, hari raya dapat membuat rasa...

The silver lining in Europe’s deforestation law delay: A chance to build fairer supply chains

When you reach for a “palm-oil-free” label at the supermarket, you likely feel you’re doing your part to save orangutans and protect biodiversity. However, the reality behind that la...